双成药业的并购“暗礁” :标的业绩暴增为何恐难持续

华尔街见闻
24 Oct 2024

发生在深交所上市公司双成药业(002693.SZ)身上的一切,像极了A股市场久违的并购造市传奇。 自9月11日宣布并购宁波奥拉半导体股份有限公司(下称“奥拉股份”)以来,双成药业股价一路连续14个交易日呈现“一字板涨停”,后经短暂调整后,再度连续拉出7个涨停。 短短1个多月内,双成药业的市值也从收购前的不到22亿元一路膨胀超过5倍。 尽管10月23日迎来股价调整,但迄今仍然位于百亿市值水位之上。 ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10